Menu Search
Equities

New Ray Medicine International Holding Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6108:HKG.HZ

New Ray Medicine International Holding Ltd

Actions
  • Price (HKD)0.242
  • Today's Change0.00 / 0.00%
  • Shares traded1.60k
  • 1 Year change-40.98%
  • Beta-0.4903
Data delayed at least 15 minutes, as of Feb 16 2026 02:40 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

New Ray Medicine International Holding Ltd is an investment holding company principally engaged in the distribution and trading of pharmaceutical and the provision of marketing and promotion services. The Company operates its businesses through two segments. The Distribution and Trading of Pharmaceutical and Related Products segment is mainly engaged in the distribution and trading of drugs and chemical reagents for pharmaceutical. The Provision of Marketing and Promotion Services segment is mainly engaged in the provision of marketing and promotion services of drugs and chemical reagents for pharmaceutical. The Company mainly operates its businesses in the domestic market.

  • Revenue in HKD (TTM)121.93m
  • Net income in HKD-34.38m
  • Incorporated2012
  • Employees30.00
  • Location
    New Ray Medicine International Holding LtdRoom 3702-03, Dikai International CenterNo. 19 Dangui RoadHANGZHOU ChinaCHN
  • Websitehttp://www.newraymedicine.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.